Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
16.30
-0.62 (-3.66%)
Jun 2, 2026, 3:04 PM CST
SHE:003020 Revenue
Hefei Lifeon Pharmaceutical had revenue of 357.10M CNY in the quarter ending March 31, 2026, a decrease of -0.87%. This brings the company's revenue in the last twelve months to 1.55B, up 0.36% year-over-year. In the year 2025, Hefei Lifeon Pharmaceutical had annual revenue of 1.55B with 2.33% growth.
Revenue (ttm)
1.55B
Revenue Growth
+0.36%
P/S Ratio
2.40
Revenue / Employee
1.06M
Employees
1,465
Market Cap
3.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55B | 35.32M | 2.33% |
| Jan 1, 2025 | 1.52B | -382.30M | -20.11% |
| Dec 31, 2023 | 1.90B | -678.55M | -26.31% |
| Jan 1, 2023 | 2.58B | 306.09M | 13.46% |
| Dec 31, 2021 | 2.27B | 378.96M | 20.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.81B |
| Wuhan Hvsen Biotechnology | 1.74B |
| Kexing Biopharm | 1.46B |
| Pulike Biological Engineering | 1.06B |
| Boji Medical Technology | 949.94M |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Jiangsu Sihuan Bioengineering | 381.71M |
| Beijing Scitop Bio-tech | 373.31M |